<DOC>
	<DOC>NCT01074242</DOC>
	<brief_summary>This survey is conducted for preparing application materials for re-examination under the Pharmaceutical Affairs Laws and its Enforcement Regulation, its aim is to reconfirm the clinical usefulness of Rotateq through collecting the safety information according to the Re-examination Regulation for New Drugs.</brief_summary>
	<brief_title>ROTATEQ Reexamination Study (V260-037)</brief_title>
	<detailed_description />
	<mesh_term>Gastroenteritis</mesh_term>
	<criteria>Infants Who Are Vaccinated With Rotateq For The Prevention Of Rotavirus Gastroenteritis Within Local Labeling Will Be Included Participants who are vaccinated with Rotateq before study start Participant who has a contraindication to Rotateq according to the local label</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>32 Weeks</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Gastroenteritis rotavirus</keyword>
</DOC>